The National Cancer Institute is offering a grant to support innovative research in isolating and characterizing extracellular vesicles (EVs) for discovering biomarkers for early cancer detection. This grant aims to promote rigor and reproducibility in both the isolation of EVs and the computational analysis of their cargo, with a focus on risk assessment, diagnosis, and prognosis of cancer. Deadline for application submission is Jan 07, 2023.
Opportunity ID: 322436
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-20-053 |
Funding Opportunity Title: | Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Nov 12, 2019 |
Last Updated Date: | Nov 12, 2019 |
Original Closing Date for Applications: | Jan 07, 2023 |
Current Closing Date for Applications: | Jan 07, 2023 |
Archive Date: | Feb 12, 2023 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Small businesses For profit organizations other than small businesses Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Private institutions of higher education Special district governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) encourages research projects that focus on innovative research in the isolation and characterization of extracellular vesicles (EVs) and their cargo for discovery of predictive biomarkers for risk assessment, detection, diagnosis and prognosis of early cancer. This FOA will promote rigor and reproducibility research in both the isolation of EVs as well as the computational analysis of the cargo carried in these vesicles. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-053.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 322436 Full Announcement-PAR-20-053 -> PAR-20-053-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259074 | Jan 05, 2020 | Jan 24, 2022 | View | |
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00256579 | Jan 05, 2020 | May 24, 2020 | View | |
FORMS-G | Use for due dates on or before January 24, 2023 | PKG00269737 | Oct 28, 2021 | Jan 24, 2023 | View | |
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277693 | Nov 01, 2022 | Jan 07, 2023 | View |
Package 1
Mandatory forms
322436 RR_SF424_2_0-2.0.pdf
322436 PHS398_CoverPageSupplement_5_0-5.0.pdf
322436 RR_OtherProjectInfo_1_4-1.4.pdf
322436 PerformanceSite_2_0-2.0.pdf
322436 RR_KeyPersonExpanded_2_0-2.0.pdf
322436 PHS398_ResearchPlan_4_0-4.0.pdf
322436 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
322436 RR_Budget_1_4-1.4.pdf
322436 RR_SubawardBudget30_1_4-1.4.pdf
322436 PHS398_ModularBudget_1_2-1.2.pdf
322436 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
322436 RR_SF424_2_0-2.0.pdf
322436 PHS398_CoverPageSupplement_4_0-4.0.pdf
322436 RR_OtherProjectInfo_1_4-1.4.pdf
322436 PerformanceSite_2_0-2.0.pdf
322436 RR_KeyPersonExpanded_2_0-2.0.pdf
322436 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
322436 RR_Budget_1_4-1.4.pdf
322436 RR_SubawardBudget30_1_4-1.4.pdf
322436 PHS398_ModularBudget_1_2-1.2.pdf
322436 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 3
Mandatory forms
322436 RR_SF424_5_0-5.0.pdf
322436 PHS398_CoverPageSupplement_5_0-5.0.pdf
322436 RR_OtherProjectInfo_1_4-1.4.pdf
322436 PerformanceSite_4_0-4.0.pdf
322436 RR_KeyPersonExpanded_4_0-4.0.pdf
322436 PHS398_ResearchPlan_4_0-4.0.pdf
322436 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
322436 RR_Budget_3_0-3.0.pdf
322436 RR_SubawardBudget30_3_0-3.0.pdf
322436 PHS398_ModularBudget_1_2-1.2.pdf
322436 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 4
Mandatory forms
322436 RR_SF424_5_0-5.0.pdf
322436 PHS398_CoverPageSupplement_5_0-5.0.pdf
322436 RR_OtherProjectInfo_1_4-1.4.pdf
322436 PerformanceSite_4_0-4.0.pdf
322436 RR_KeyPersonExpanded_4_0-4.0.pdf
322436 PHS398_ResearchPlan_5_0-5.0.pdf
322436 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
322436 RR_Budget_3_0-3.0.pdf
322436 RR_SubawardBudget30_3_0-3.0.pdf
322436 PHS398_ModularBudget_1_2-1.2.pdf
322436 PHS_AssignmentRequestForm_3_0-3.0.pdf